Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Melike Ozcelik"'
Autor:
Dincer Aydin, Umut Kefeli, Melike Ozcelik, Gokmen Umut Erdem, Mehmet Ali Sendur, Mahmut Emre Yildirim, Basak Bala Oven, Ahmet Bilici, Mahmut Gumus
Publikováno v:
Medicina, Vol 59, Iss 8, p 1472 (2023)
Background and Objectives: Small bowel adenocarcinomas (SBAs) are rare tumors of the gastrointestinal system. Lymph node metastasis in patients with curatively resected SBAs is associated with poor prognosis. In this study, we determined the prognost
Externí odkaz:
https://doaj.org/article/3b3c8278b97c4da0b5c9f034616c34e9
Autor:
Hatice Odabas, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, Mahmut Gumus
Publikováno v:
Medicina, Vol 59, Iss 3, p 557 (2023)
Background and Objectives: This investigation aimed to determine the impacts of concurrent proton pump inhibitors (PPIs) on progression-free survival (PFS) in patients with hormone receptor-positive and HER2-negative metastatic breast cancer managed
Externí odkaz:
https://doaj.org/article/0e0b7c0de82c401fb9197cf40efeed4d
Autor:
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Burcin Cakan Demirel, Omer Acar, Sercan Aksoy, Naziyet Kose Baytemur, Elif Sahin, Devrim Cabuk, Gul Basaran, Semra Paydas, Arzu Yaren, Deniz Can Guven, Atike Pinar Erdogan, Umut Demirci, Alper Yasar, İbrahim Vedat Bayoglu, Mutlu Hizal, Burcu Gulbagci, Nail Paksoy, Sena Ece Davarci, Funda Yilmaz, Ozlem Dogan, Sibel Oyucu Orhan, Erkan Kayikcioglu, Ali Aytac, Merve Keskinkilic, Eda Eylemer Mocan, Olcun Umit Unal, Esra Aydin, Hakan Yucel, Deniz Isik, Onder Eren, Basak Oyan Uluc, Melike Ozcelik, Ilhan Hacibekiroglu, Adnan Aydiner, Hacer Demir, Berna Oksuzoglu, Ebru Cilbir, Erdem Cubukcu, Bulent Cetin, Esin Oktay, Cihan Erol, Sadi Kerem Okutur, Nilgun Yildirim, Ali Alkan, Fatih Selcukbiricik, Asude Aksoy, Yusuf Karakas, Gulhan Ozkanli, Berna Bozkurt Duman, Dincer Aydin, Ozgecan Dulgar, Muhammed Muhiddin Er, Fatih Teker, Tugba Yavuzsen, Musa Baris Aykan, Ali Inal, Yakup Iriagac, Nurhan Onal Kalkan, Murat Keser, Teoman Sakalar, Serkan Menekse, Engin Kut, Burak Bilgin, Muge Karaoglanoglu, Veli Sunar, Ozlem Ozdemir, Nazim Serdar Turhal, Nuri Karadurmus, Bulent Yalcin, Mehmet Ali Nahit Sendur
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4603b0dea982cdc71feb0666817cb5
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:462-465
Introduction Nivolumab is a human immunoglobulin G4 monoclonal antibody that inhibits programmed cell death-1 activity by binding to the programmed cell death-1 receptors. Cancer cells express increased number of programmed cell death-1 ligands and t
Autor:
Ayse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, Lokman Koral, Melih Şimşek, Çağlayan Geredeli, Akın Öztürk, Perihan Perkin, Derya Demirtaş, Engin Erdemoglu, İlhan Hacıbekiroglu, Emre Çakır, Eda Tanrıkulu, Ezgi Çoban, Melike Ozcelik, Sinemis Çelik, Fatih Teker, Asude Aksoy, Sedat T Fırat, Ömer Tekin, Ziya Kalkan, Orhan Türken, Bala B Oven, Faysal Dane, Ahmet Bilici, Abdurrahman Isıkdogan, Mesut Seker, Hacı M Türk, Mahmut Gümüş
Publikováno v:
Future Oncology
Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against SARS-CoV-2 were measured in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce80e141c2165fb933786d2089960e2a
https://hdl.handle.net/11424/286170
https://hdl.handle.net/11424/286170
Autor:
Tugba Kizilboga Akgun, Fikret Ezberci, Melike Ozcelik, Sezin Canbek, Elifnaz Celik, Ebru Zemheri, Levent Doganay, Nihat Bugra Agaoglu, Gizem Alkurt, Jale Yıldız, Feruze Yilmaz Enc, Gözde Kir, Izzet Mehmet Akcay, Ali Kılıç, Gizem Dinler Doganay
Publikováno v:
International Journal of Cancer. 148:285-295
Inherited pathogenic variants account for 5% to 10% of all breast cancer (BC) and colorectal cancer (CRC) cases. Here, we sought to profile the pathogenic variants in 25 cancer susceptibility genes in Turkish population. Germline pathogenic variants
Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
Autor:
Mustafa Degirmenci, Melike Ozcelik, Mehmet Aliustaoglu, Mahmut Gumus, Heves Sürmeli, Deniz Tataroğlu, Mevlude Inanc, Ozlem Ercelep
Publikováno v:
Turkish Journal of Obstetrics and Gynecology
Turkish Journal of Obstetrics and Gynecology, Vol 17, Iss 2, Pp 123-127 (2020)
Turkish Journal of Obstetrics and Gynecology, Vol 17, Iss 2, Pp 123-127 (2020)
Objective To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer. Materials and methods Data o
Publikováno v:
Archives of Medical Science : AMS
IntroductionTo evaluate the efficacy and safety of transition from premixed and intensive insulin to twice-daily insulin degludec/aspart (IDegAsp) co-formulation in patients with type 2 diabetes mellitus.Material and methodsIn this 12-week study, pat
Autor:
Serhat Özçelik, Rifat Bircan, Melike Ozcelik, Aylin Ege Gul, Akin Dayan, Nimet Karadayi, Mehmet Celik, Sukran Sarikaya, Busra Aydin, Yasemin Tutuncu, Hasret Cengiz, Hulya Iliksu Gozu
Publikováno v:
Endokrynologia Polska. 70:401-408
Introduction: BRAF(V600E) activating mutation is the most frequent genetic abnormality in the pathogenesis of papillary thyroid carcinoma. We aimed to evaluate the association between BRAF(V600E )mutation and well-established prognostic clinicopathol
Autor:
Süleyman Baş, Melike Ozcelik, Mehmet Celik, Hulya Iliksu Gozu, Serhat Özçelik, Mehmet Sariaydin
Publikováno v:
Archives of Endocrinology and Metabolism, Issue: ahead, Published: 25 OCT 2021
Archives of Endocrinology and Metabolism, Volume: 65, Issue: 5, Pages: 617-624, Published: 29 SEP 2021
Archives of Endocrinology and Metabolism v.65 n.5 2021
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Vol 65, Iss 5, Pp 617-624 (2021)
Archives of Endocrinology and Metabolism, Volume: 65, Issue: 5, Pages: 617-624, Published: 29 SEP 2021
Archives of Endocrinology and Metabolism v.65 n.5 2021
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Vol 65, Iss 5, Pp 617-624 (2021)
Objective: We aimed to investigate the role of testosterone to estradiol ratio in predicting the effectiveness of human chorionic gonadotropin and testosterone treatments in male hypogonadism. Materials and methods: Thirty-six male patients with hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86822c51d248efe293037b605b43227
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021005009204&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021005009204&lng=en&tlng=en